Tirzepatide Demonstrates Reduction in Sleep Apnea-Relate Events
Eli Lilly and Company will submit results of the study to support tirzepatide (Zepbound) for treatment of obstructive sleep apnea later this year.
Source: pharmacytimes.com
Stay updated with breaking news from Apnea Statistics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Eli Lilly and Company will submit results of the study to support tirzepatide (Zepbound) for treatment of obstructive sleep apnea later this year.